28/08/2013 | 17:35 CEST | Group Announcements
Staefa (Switzerland), 28 August 2013 – Sonova Holding AG, the world’s leading provider of hearing solutions, announces today that its subsidiary Advanced Bionics (AB) has received FDA (Food and Drug Administration) approval in the United States for its new Naída CI Q70 (Naída CI) sound processor. With this approval, the product is now commercially available in the United States. Earlier this year, the Naída CI processor received regulatory approval for distribution in Europe, Canada and several other countries in the world.
With Naída CI, the innovation DNA of AB and Phonak have merged together for the introduction of the world’s newest, most advanced behind-the-ear sound processor. Now cochlear implant recipients have access to the combined technologies of the innovation leaders in cochlear implants and hearing instruments.
Naída CI comes with a full performance package in a small size. Significantly improved speech perception, unique ear-to-ear communication and 100% wireless connectivity to consumer electronics together with a 40% size reduction compared to AB's previous behind-the-ear processor are just a few of the new processor’s myriad of features. For more information, please visit AdvancedBionics.com.
– End –